HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angela Macleod Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

6/2003Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angela Macleod Research Topics

Disease

1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2003
1Pain (Aches)
09/2002

Drug/Important Bio-Agent (IBA)

1Gefitinib (Iressa)FDA Link
06/2003
1ErbB Receptors (EGF Receptor)IBA
06/2003
1Tyrosine Kinase InhibitorsIBA
06/2003
1High-Q-Bond (Ideal 1)IBA
06/2003
1Capsaicin (Zostrix)FDA Link
09/2002